Skip to main content

Table 1 Socio-demographic and clinical characteristics of chronic hepatitis B patients

From: Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls

  Overall (n = 460) Chronic hepatitis B (n = 323) Compensated cirrhosis (n = 54) Decompensated cirrhosis (n = 83)
Age (years, mean ± SD) 35.8 ± 12.8 31.5 ± 10.9 43.0 ± 10.3 47.4 ± 11.7
Sex (%)     
Male 66.3 65.6 72.2 65.1
Female 33.7 34.4 27.8 34.9
Occupation (%)     
Peasants 33.3 22.6 48.1 65.1
Service and commercial workers 17.0 18.9 14.8 10.9
Enterprise and institution staff 13.3 14.9 14.8 6.0
Unemployees 13.2 16.1 5.6 7.2
Self-employed persons 8.0 9.3 7.4 3.6
Students 7.4 10.5 0.0 0.0
Others 7.8 7.7 9.3 7.2
Education attainment (%)     
No schooling and primary 13.7 9.6 20.4 25.3
Secondary 67.6 67.2 66.7 69.9
Tertiary 18.7 23.2 12.9 4.8
Marital status (%)     
Married 71.3 61.9 96.3 91.6
Other marital status 28.7 38.1 3.7 8.4
Annual per capita household income (Chinese $, %)     
<5000 51.3 45.5 61.1 67.5
5000–9999 24.1 27.3 18.5 15.7
≥10000 24.6 27.2 20.4 16.8
Duration of illness (years, mean ± SD) 6.1 ± 6.9 6.0 ± 6.5 6.4 ± 6.7 6.3 ± 8.2
Currently taken anti-viraltreatment (%)     
No 61.1 67.2 50.0 44.6
Yes 38.9 32.8 50.0 55.4
Liver function tests*     
ALT (U/L, mean ± SD) 61.9 ± 95.0 62.1 ± 100.2 52.4 ± 40.9 70.4 ± 83.1
TBIL (umol/L, mean ± SD) 19.7 ± 20.3 16.5 ± 7.3 24.8 ± 13.7 46.7 ± 60.4
ALB (g/L, mean ± SD) 44.1 ± 4.8 45.0 ± 4.0 42.7 ± 4.7 36.0 ± 4.6
  1. ALT, alanine aminotransferase; TBIL, total bilirubin; ALB, albumin.
  2. *Only including 375 patients receiving liver function tests: 311, 34 and 30 in chronic hepatitis B, compensated cirrhosis and decompensated cirrhosis groups, respectively.
  3. Significant difference among three patient groups (P < 0.05).